Maturation, activation, and protection of dendritic cells induced by double-stranded RNA

Journal of Experimental Medicine

Volumn 189, Issue 5, 1999, Pages 821-829

  Cella, Marina ^a   Salio, Mariolina ^a   Sakakibara, Yoichi ^a   Langen, Hanno ^b   Julkunen, Ilkka ^c   Lanzavecchia, Antonio ^a  

^a BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Dendritic cell maturation and activation; Double stranded RNA; Influenza virus; MxA; Type I interferon

Indexed keywords

DOUBLE STRANDED RNA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; CELL MATURATION; CELL MIGRATION; CELL PROTECTION; DENDRITIC CELL; ENDOCYTOSIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MACROPHAGE ACTIVATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; RECEPTOR UPREGULATION;

ANTIGEN PRESENTATION; ANTIVIRAL AGENTS; AUTOCRINE COMMUNICATION; CYTOPATHOGENIC EFFECT, VIRAL; DENDRITIC CELLS; GTP-BINDING PROTEINS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERFERON-ALPHA; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; ORTHOMYXOVIRIDAE; PEPTIDES; PROTEIN BIOSYNTHESIS; RNA, DOUBLE-STRANDED; T-LYMPHOCYTES; TH1 CELLS;

EID: 0033103128     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.5.821     Document Type: Article

References (43)

1. Banchereau, J., and R.M. Steinman. 1998. Dendritic cells and the control of immunity. Nature. 392:245-252.
2. Steinman, R.M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271-296.
3. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179:1109-1118.
4. Sallusto, F., M. Cella, C. Danieli, and A. Lanzavecchia. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182:389-400.
5. Cella, M., A. Engering, V. Pinet, J. Pieters, and A. Lanzavecchia. 1997. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature. 388:782-787.
6. Pierre, P., S.J. Turley, E. Gatti, M. Hull, J. Meltzer, A. Mirza, K. Inaba, R.M. Steinman, and I. Mellman. 1997. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature. 388:787-792.
7. Braciale, T.J., and K.L. Yap. 1978. Role of viral infectivity in the induction of influenza virus-specific cytotoxic T cells. J. Exp. Med. 147:1236-1252.
8. Yewdell, J.W., J.R. Bennink, and Y. Hosaka. 1988. Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. Science. 239:637-640.
9. Townsend, A.R., J. Rothbard, F.M. Gotch, G. Bahadur, D. Wraith, and A.J. McMichael. 1986. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell. 44:959-968.
10. Gotch, F., J. Rothbard, K. Howland, A. Townsend, and A. McMichael. 1987. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. Nature. 326:881-882.
11. + T cells. J. Clin. Invest. 94:797-807.
12. Bender, A., M. Albert, A. Reddy, M. Feldman, B. Sauter, G. Kaplan, W. Hellman, and N. Bhardwaj. 1998. The distinctive features of influenza virus infection of dendritic cells. Immunobiology. 198:552-567.
13. + cytolytic T cell responses. J. Exp. Med. 182:1663-1671.
14. Albert, M.L., B. Sauter, and N. Bhardwaj. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature. 392:86-89.
15. Ridge, J.P., F. Di Rosa, and P. Matzinger. 1998. A conditioned dendritic cell can be a temporal bridge between a CD4 T helper and a T killer cell. Nature. 393:474-478.
16. Mogensen, K.E., L. Pyhala, and K. Cantell. 1995. Raising antibodies to human leukocyte interferon. Acta Pathol. Microbiol. Scand. Suppl. 83:443-448.
17. Ronni, T., K. Melen, A. Malygin, and I. Julkunen. 1993. Control of IFN-inducible MxA gene expression in human cells. J. Immunol 150:1715-1726.
18. Caton, A.J., J.R. Swartzentruber, A.L. Kuhl, S.R. Carding, and S.E. Stark. 1996. Activation and negative selection of functionally distinct subsets of antibody-secreting cells by influenza hemagglutinin as a viral and a neo-self-antigen. J. Exp. Med. 183:13-26.
19. Cella, M., D. Scheidegger, K. Palmer Lehmann, P. Lane, A. Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin 12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184:747-752.
20. Nederman, T., E. Karlstrom, and L. Sjodin. 1990. An in vitro bioassay for quantitation of human interferons by measurements of antiproliferative activity on a continuous human lymphoma cell line. Biologicals. 18:29-34.
21. Valitutti, S., S. Mueller, M. Dessing, and A. Lanzavecchia. 1996. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J. Exp. Med. 183:1917-1921.
22. Pavlovic, J., H.A. Arzet, H.P. Hefti, M. Frese, D. Rost, B. Ernst, E. Kolb, P. Staeheli, and O. Haller. 1995. Enhanced virus resistance of transgenic mice expressing the human MxA protein. J. Virol. 69:4506-4510.
23. Pavlovic, J., O. Haller, and P. Staeheli. 1992. Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle. J. Virol. 66:2564-2569.
24. Meurs, E., K. Chong, J. Galabru, N.S. Thomas, I.M. Kerr, B.R. Williams, and A.G. Hovanessian. 1990. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell. 62:379-390.
25. Kumar, A., J. Haque, J. Lacoste, J. Hiscott, and B.R. Williams. 1994. Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. Proc. Natl. Acad. Sci. USA. 91:6288-6292.
26. O'Garra, A. 1998. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity. 8:275-283.
27. Bender, A., M. Sapp, G. Schuler, R.M. Steinman, and N. Bhardwaj. 1996. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J. Immunol. Methods. 196:121-135.
28. Field, A.K., A.A. Tytell, G.P. Lampson, and M.R. Hilleman. 1967. Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes. Proc. Natl. Acad. Sci. USA. 58:1004-1010.
29. Pestka, S., J.A. Langer, K.C. Zoon, and C.E. Samuel. 1987. Interferons and their actions. Annu. Rev. Biochem. 56:727-777.
30. Manetti, R., F. Annunziato, L. Tomasevic, V. Gianno, P. Parronchi, S. Romagnani, and E. Maggi. 1995. Polyinosinic acid: polycytidylic acid promotes T helper type 1-specific immune responses by stimulating macrophage production of interferon-alpha and interleukin-12. Eur. J. Immunol. 25: 2656-2660.
31. van den Broek, M.F., U. Muller, S. Huang, M. Aguet, and R.M. Zinkernagel. 1995. Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. J. Virol. 69: 4792-4796.
32. Muller, U., U. Steinhoff, L.F. Reis, S. Hemmi, J. Pavlovic, R.M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science. 264: 1918-1921.
33. Perussia, B., V. Fanning, and G. Trinchieri. 1985. A leukocyte subset bearing HLA-DR antigens is responsible for in vitro alpha interferon production in response to viruses. Nat. Immun. Cell Growth Regul. 4:120-137.
34. Pavlovic, J., T. Zurcher, O. Haller, and P. Staeheli. 1990. Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J. Virol. 64: 3370-3375.
35. Ronni, T., T. Sareneva, J. Pirhonen, and I. Julkunen. 1995. Activation of IFN-alpha, IFN-gamma, MxA, and IFN regulatory factor 1 genes in influenza A virus-infected human peripheral blood mononuclear cells. J. Immunol. 154:2764-2774.
36. Luft, T., K.C. Pang, E. Thomas, P. Hertzog, D.N. Hart, J. Trapani, and J. Cebon. 1998. Type I IFNs enhance the terminal differentiation of dendritic cells. J. Immunol. 161:1947-1953.
37. Yang, Y.L., L.F. Reis, J. Pavlovic, A. Aguzzi, R. Schafer, A. Kumar, B.R. Williams, M. Aguet, and C. Weissmann. 1995. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO (Eur. Mol. Biol. Organ.) J. 14:6095-6106.
38. Medzhitov, R., and C.A. Janeway, Jr. 1997. Innate immunity: the virtues of a nonclonal system of recognition. Cell. 91:295-298.
39. Kitajewski, J., R.J. Schneider, B. Safer, S.M. Munemitsu, C.E. Samuel, B. Thimmappaya, and T. Shenk. 1986. Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase. Cell. 45:195-200.
40. Katze, M.G. 1995. Regulation of the interferon-induced PKR: can viruses cope? Trends Microbiol. 3:75-78.
41. Jacobs, B.L., and J.O. Langland. 1996. When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology. 219:339-349.
42. Rogge, L., L. Barberis-Maino, M. Biffi, N. Passini, D.H. Presky, U. Gubler, and F. Sinigaglia. 1997. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185:825-831.
43. Kaser, A., C. Molnar, and H. Tilg. 1998. Differential regulation of interleukin 4 and interleukin 13 production by interferon alpha. Cytokine. 10:75-81.